Continuous glucose monitoring in older adults with diabetes: Data from the diabetes prospective follow-up (DPV) registry
- PMID: 38009855
- DOI: 10.1111/dme.15261
Continuous glucose monitoring in older adults with diabetes: Data from the diabetes prospective follow-up (DPV) registry
Abstract
Aims: To analyse predictors for continuous glucose monitoring (CGM) use in people with diabetes aged ≥60 years using insulin therapy and to assess the rates of CGM use during recent years (2019-2021).
Research design and methods: Prospective study including 6849 individuals with diabetes and insulin therapy (type 2 diabetes: n = 5320; type 1 diabetes: n = 1529) aged ≥60 years. Data from 129 treatment centres were retrieved from the Diabetes Prospective Follow-up Registry (DPV) in March 2023.
Results: Sensor use in individuals aged ≥60 years has increased in type 1 (2019: 28%, 2020: 39%, 2021: 45%) and type 2 diabetes (2019: 10%, 2020: 16%, 2021: 18%). Predictors for sensor use in older individuals with type 1 diabetes are younger age and CSII use (p < 0.001). Predictors in older individuals with type 2 diabetes are younger age, longer diabetes duration, higher BMI and CSII use (p < 0.001).
Conclusions: CGM has become more common in older adults with diabetes and will presumably increase further. Age is a predictor for sensor use in older adults with diabetes. Age-related physical barriers and insufficient usability of devices, lack of interest in technologies, but possibly also effects of prejudice on the grounds of age may contribute to this finding.
Keywords: CGM; DPV registry; continuous glucose monitoring; elderly; type 1 diabetes; type 2 diabetes.
© 2023 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
References
REFERENCES
-
- Teo E, Hassan N, Tam W, Koh S. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia. 2022;65:604-619. doi:10.1007/s00125-021-05648-4
-
- Ida S, Kaneko R, Murata K. Utility of real-time and retrospective continuous glucose monitoring in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. J Diabetes Res. 2019;2019:4684815. doi:10.1155/2019/4684815
-
- Lanzinger S, Best F, Bergmann T, et al. Dynamics of hemoglobin A1c, body mass index, and rates of severe hypoglycemia in 4434 adults with type 1 or type 2 diabetes after initiation of continuous glucose monitoring. Diabetes Technol Ther. 2022;24(10):763-769. doi:10.1089/dia.2022.0063
-
- Gavin JR, Clifford J, Bailey CJ. Real-world studies support use of continuous glucose monitoring in type 1 and type 2 diabetes independently of treatment regimen. Diabetes Technol Ther. 2021;23(3):19-27.
-
- Sinclair A, Saeedi P, Kaundal A, Karuranga S, Malanda B, Williams R. Diabetes and global ageing among 65-99-year-old adults: findings from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2020;162:108078.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical